Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004876
Filing Date
2019-05-10
Accepted
2019-05-10 17:23:55
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20190331x10q.htm 10-Q 1107629
2 EX-31.1 ampe-20190331ex311996521.htm EX-31.1 18899
3 EX-31.2 ampe-20190331ex31211e7a3.htm EX-31.2 18785
4 EX-32.1 ampe-20190331ex3210ff817.htm EX-32.1 10088
5 GRAPHIC ampe20190331x10q001.jpg GRAPHIC 4975
  Complete submission text file 0001558370-19-004876.txt   4717029

Data Files

Seq Description Document Type Size
6 EX-101.INS ampe-20190331.xml EX-101.INS 1057875
7 EX-101.SCH ampe-20190331.xsd EX-101.SCH 36251
8 EX-101.CAL ampe-20190331_cal.xml EX-101.CAL 25609
9 EX-101.DEF ampe-20190331_def.xml EX-101.DEF 148305
10 EX-101.LAB ampe-20190331_lab.xml EX-101.LAB 276394
11 EX-101.PRE ampe-20190331_pre.xml EX-101.PRE 259262
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 19816103
SIC: 2834 Pharmaceutical Preparations